Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 86 clinical trials
Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients

Prevention System to prevent chemotherapy-induced alopecia. This project seeks to demonstrate that the Orbis Paxman Hair Loss Prevention System is safe and effective in reducing chemotherapy-induced

  • 0 views
  • 14 May, 2022
  • 1 location
PBMT for the Management of CIA ( HAIRLASER )

-induced alopecia (CIA) occurs in about 65% of the patients. Hair loss due to CT is reversible, but hair regrowth requires several months to a year after CT. Currently, the only available preventive

anthracycline
breast adenocarcinoma
taxane
scalp cooling
cancer
  • 0 views
  • 08 Apr, 2022
  • 1 location
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

mediators
atopy
unbalanced translocation
skin disease
skin disorder
  • 88 views
  • 17 Jun, 2022
  • 1 location
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

acne
skin disease
skin lesion
hair loss
skin lesions
  • 206 views
  • 20 Apr, 2022
  • 1 location
Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients

This study aims to examine whether the PSCS2 is effective in reducing chemotherapy-induced alopecia in woman with breast cancer undergoing neoadjuvant or adjuvant chemotherapy. Female adults who

adjuvant chemotherapy
taxane
adriamycin
  • 0 views
  • 20 Aug, 2021
  • 1 location
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

An open label, pilot study involving the use of low dose oral minoxidil to treat permanent chemotherapy-induced alopecia.

  • 63 views
  • 14 Jun, 2022
  • 1 location
Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia

-induced alopecia (CIA) affects up to 65% of the patients. This condition is reversible. Nevertheless, it takes several months after CT for visible hair regrowth. Different characteristics of the new hair

taxane
docetaxel
paclitaxel
  • 0 views
  • 19 Jun, 2022
  • 1 location
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

This study is being done to determine if using the Paxman Scalp Cooling System at temperatures lower than the current standard is a safe and tolerable approach to prevent hair loss in breast

anthracyclines
taxane
adjuvant chemotherapy
breast cancer stage i
immunostimulant
  • 12 views
  • 01 Jul, 2022
  • 1 location
Scalp Cooling in MBC

This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling after receiving standard of care

  • 0 views
  • 23 Mar, 2022
  • 2 locations
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).

  • 10 views
  • 05 Jun, 2022
  • 1 location